Literature DB >> 27692993

[Craniofacial strategy for syndromic craniosynostosis].

E Arnaud1, G Paternoster2, S James3, M-P Morisseau-Durand4, V Couloigner5, P Diner6, C Tomat6, V Viot-Blanc7, B Fauroux8, V Cormier-Daire9, G Baujat9, M Robert10, A Picard11, S Antunez2, R Khonsari6, L Pamphile-Tabuteau2, C Legros12, M Zerah2, P Meyer11.   

Abstract

The complexity of treatment of faciocraniosynostosis justifies the treatment in a reference center for rare diseases. The growth disturbances in the skull and face being variable according to the type of mutation in the FGFr (Crouzon, Pfeiffer, Apert), the strategy is adapted to the phenotype according to the following principles: posterior expansion with or without distraction around 6 months to limit the descent of the cerebellum tonsils and to prevent the turricephalic development; fronto-facial monobloc advancement with internal distraction around the age of 18 months in case of severe exorbitism or breathing impairment. The dissociated strategy (fronto-orbital advancement first, followed by facial osteotomy of Le Fort 3 type). The growing evolution dictates the sequence of subsequent surgeries according to the monitoring of intracranial pressure by fundus examination and of the respiration by polysomnography. Le Fort 3 and transversal maxillary distraction may be repeated if necessary. Orthognathic surgery is almost always compulsory after the age of 14, before the aesthetic refinements which can be undertaken ultimately (rhinoplasty, genioplasty, canthopexies, fat grafting…).
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Centre de référence; Chirurgie craniofaciale; Craniofacial; Craniosténoses syndromiques; Osteodistraction; Osteotomies; Ostéodistraction; Ostéotomies; Syndromic craniosynostosis; Teamwork

Mesh:

Year:  2016        PMID: 27692993     DOI: 10.1016/j.anplas.2016.08.008

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  1 in total

1.  Pfeiffer Syndrome: A Therapeutic Algorithm Based on a Modified Grading Scale.

Authors:  Cassio Eduardo Raposo-Amaral; Rafael Denadai; Geiza Máximo; Cesar Augusto Raposo-Amaral; Enrico Ghizoni
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.